Sucksdorff, Marcus
Åbo Akademi University · University of Turku · Turku University Hospital · Turku PET Centre
8 papers on CoChatORCID 0000-0003-0432-2931
Most cited papers
- Verified
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis
Sucksdorff, M., Matilainen, M., Tuisku, J., Polvinen, E., Vuorimaa, A., Rokka, J., Nylund, M., Rissanen, E., & Airas, L. (2020) · Brain
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 142
- Verified
Natalizumab treatment reduces microglial activation in the white matter of the MS brain
Sucksdorff, M., Tuisku, J., Matilainen, M., Vuorimaa, A., Smith, S., Keitilä, J., Rokka, J., Parkkola, R., Nylund, M., Rinne, J., et al. (2019) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 71
- Verified
Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging
Bezukladova, S., Tuisku, J., Matilainen, M., Vuorimaa, A., Nylund, M., Smith, S., Sucksdorff, M., Mohammadian, M., Saunavaara, V., Laaksonen, S., et al. (2020) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesAdvanced Neuroimaging Techniques and Applications
Cited by 49
- Verified
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET
Nylund, M., Sucksdorff, M., Matilainen, M., Polvinen, E., Tuisku, J., & Airas, L. (2022) · Brain Communications
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 48
- Verified
TSPO-detectable chronic active lesions predict disease progression in multiple sclerosis
Polvinen, E., Matilainen, M., Nylund, M., Sucksdorff, M., & Airas, L. M. (2023) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 36
- Verified
Association of serum neurofilament light with microglial activation in multiple sclerosis
Saraste, M., Matilainen, M., Vuorimaa, A., Laaksonen, S., Sucksdorff, M., Leppert, D., Kuhle, J., & Airas, L. (2023) · Journal of Neurology, Neurosurgery & Psychiatry
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 33
- Verified
Innate immune cell-related pathology in the thalamus signals a risk for disability progression in multiple sclerosis
Misin, O., Matilainen, M., Nylund, M., Honkonen, E., Rissanen, E., Sucksdorff, M., & Airas, L. (2022) · Neurology Neuroimmunology & Neuroinflammation
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 24
- Verified
PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: A case report
Lehto, J., Sucksdorff, M., Nylund, M., Raitanen, R., Matilainen, M., & Airas, L. (2023) · Journal of Neurology
Multiple Sclerosis Research StudiesNeuroinflammation and Neurodegeneration Mechanisms
Cited by 4
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free